TY - JOUR
T1 - Catalysing Artificial Intelligence for Paediatric Tuberculosis Research (CAPTURE)
T2 - protocol for a global multicentre study establishing a paediatric chest X-ray repository to evaluate computer-aided detection algorithms
AU - Palmer, Megan
AU - Kik, Sandra Vivian
AU - Kohli, Mikashmi
AU - Fataar, Aaqilah
AU - Anyebe, Victor
AU - Frey, Nathalie
AU - Castro, Robert
AU - Nerurkar, Rutuja
AU - Van Der Westhuizen, Joh Nell
AU - Macé, Aurélien
AU - Ruhwald, Morten
AU - Seddon, James A.
AU - Jaganath, Devan
AU - Amanullah, Farhana
AU - Anderson, Suzanne T.
AU - Andronikou, Savvas
AU - Aurilio, Rafaela Baroni
AU - Balestre, Eric
AU - Borand, Laurence
AU - Breton, Guillaume
AU - Bonnet, Maryline
AU - Chabala, Chishala
AU - Chagaluka, George
AU - Daware, Rahul
AU - Franke, Molly F.
AU - García-Basteiro, Alberto L.
AU - Goussard, Pierre
AU - Gupta, Amita
AU - Gupte, Nikhil
AU - Hesseling, Anneke C.
AU - Kamath, Pragathi
AU - Khosa, Celso
AU - Kinikar, Aarti
AU - LaCourse, Sylvia
AU - Leroy-Terquem, Etienne
AU - Lopez-Varela, Elisa
AU - Marcy, Olivier
AU - Mave, Vidya
AU - Mint, Aye Aye
AU - Moh, Raoul
AU - Mwanga-Amumpaire, Juliet
AU - Myo, Kyaw
AU - Nduba, Videlis
AU - Nliwasa, Marriott
AU - Ntinginya, Nyanda Elias
AU - Olbrich, Laura
AU - Otero, Hansel J.
AU - Paradkar, Mandar
AU - Parente, Ana Alice I.
AU - Peinado, Jesus
AU - Mascarenhas, Michely A.Pinheiro
AU - Pitcher, Richard
AU - Poublan, Julien
AU - Ribeiro, Jorge
AU - Sabi, Issa
AU - Sant Anna, Clemax C.
AU - Schaaf, H. Simon
AU - Taguebue, Jean Voisin
AU - Van Der Zalm, Marieke M.
AU - Walters, Elisabetta
AU - Wobudeya, Eric
AU - Zar, Heather J.
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.
PY - 2026/1/12
Y1 - 2026/1/12
N2 - Introduction The substantial case detection gap in the field of child tuberculosis (TB) disease is largely driven by inadequate diagnostic tools and approaches. Chest radiographs (CXRs) remain a key component in the evaluation of children and young adolescents (0-15 years) with presumptive TB, aiding clinicians in making the diagnosis and discriminating children with TB from those with other diseases. Widespread use and optimal interpretation of CXR is hampered by a lack of access to well-trained specialists to interpret images. Artificial intelligence CXR interpretation software, termed computer-aided detection (CAD), is now well developed for adults, yet few products have been evaluated in children. The CXR features of child TB are different from those of adults, and as a result, the performance of these CAD algorithms, largely developed for use in adults, will be suboptimal when used in children. Adapting, or fine-tuning adult CAD algorithms, using CXR images from children with presumptive TB, could allow optimisation of these products for use in children. We, therefore, set out to develop a large image and data repository collected from children evaluated for TB (called Catalysing Artificial Intelligence for Paediatric Tuberculosis Research, CAPTURE) with the purpose of evaluating current CAD products and then working with developers and other partners to optimise CAD algorithms for use in children. Methods and analysis We identified approximately 20 studies, from which potentially up to 11 000 CXRs could be used for the proposed project. CXRs and data were eligible for inclusion in the CAPTURE repository if collected from high-quality child TB diagnostic studies that enrolled children with presumptive TB and if CXRs were obtained as part of the baseline assessment. All lead investigators of these studies are members of the CAPTURE consortium. The images and metadata contributed are centrally collated and the key variable of TB case classification as confirmed, unconfirmed or unlikely TB, using an established consensus case definition, is available. All CXRs included in the CAPTURE repository have a consensus radiological interpretation allocated by a panel of independent expert child TB CXR readers who have classified them as 'unreadable', 'normal', 'abnormal typical of TB' or 'abnormal not typical of TB'. To determine diagnostic performance of existing CAD products, we will evaluate these against a primary composite clinical reference standard (confirmed TB and unconfirmed TB vs unlikely TB), as well as other secondary microbiological and radiological reference standards. A subset of images will be subsequently allocated to a 'training set' and made available to developers, academic groups or other parties to either develop novel paediatric CAD products or fine-tune existing adult ones, which will then be re-evaluated by the CAPTURE team using an image subset ('validation set') that is independent of the training set. Ethics and dissemination The CAPTURE study has been approved by Stellenbosch University Health Research Ethics Committee (N22/09/113), with additional ethics approval or waivers by relevant local authorities obtained by consortium members contributing data if required. The final pooled, harmonised and cleaned dataset, as well as the deidentified, renamed CXR images, is stored on a secure cloud-based server. All analyses of existing CAD products, as well as the paediatric-optimised products, will be published in peer-reviewed publications and shared with other stakeholders like the WHO and donor and procurement organisations to guide policy updates and procurement pathways to ensure widespread uptake.
AB - Introduction The substantial case detection gap in the field of child tuberculosis (TB) disease is largely driven by inadequate diagnostic tools and approaches. Chest radiographs (CXRs) remain a key component in the evaluation of children and young adolescents (0-15 years) with presumptive TB, aiding clinicians in making the diagnosis and discriminating children with TB from those with other diseases. Widespread use and optimal interpretation of CXR is hampered by a lack of access to well-trained specialists to interpret images. Artificial intelligence CXR interpretation software, termed computer-aided detection (CAD), is now well developed for adults, yet few products have been evaluated in children. The CXR features of child TB are different from those of adults, and as a result, the performance of these CAD algorithms, largely developed for use in adults, will be suboptimal when used in children. Adapting, or fine-tuning adult CAD algorithms, using CXR images from children with presumptive TB, could allow optimisation of these products for use in children. We, therefore, set out to develop a large image and data repository collected from children evaluated for TB (called Catalysing Artificial Intelligence for Paediatric Tuberculosis Research, CAPTURE) with the purpose of evaluating current CAD products and then working with developers and other partners to optimise CAD algorithms for use in children. Methods and analysis We identified approximately 20 studies, from which potentially up to 11 000 CXRs could be used for the proposed project. CXRs and data were eligible for inclusion in the CAPTURE repository if collected from high-quality child TB diagnostic studies that enrolled children with presumptive TB and if CXRs were obtained as part of the baseline assessment. All lead investigators of these studies are members of the CAPTURE consortium. The images and metadata contributed are centrally collated and the key variable of TB case classification as confirmed, unconfirmed or unlikely TB, using an established consensus case definition, is available. All CXRs included in the CAPTURE repository have a consensus radiological interpretation allocated by a panel of independent expert child TB CXR readers who have classified them as 'unreadable', 'normal', 'abnormal typical of TB' or 'abnormal not typical of TB'. To determine diagnostic performance of existing CAD products, we will evaluate these against a primary composite clinical reference standard (confirmed TB and unconfirmed TB vs unlikely TB), as well as other secondary microbiological and radiological reference standards. A subset of images will be subsequently allocated to a 'training set' and made available to developers, academic groups or other parties to either develop novel paediatric CAD products or fine-tune existing adult ones, which will then be re-evaluated by the CAPTURE team using an image subset ('validation set') that is independent of the training set. Ethics and dissemination The CAPTURE study has been approved by Stellenbosch University Health Research Ethics Committee (N22/09/113), with additional ethics approval or waivers by relevant local authorities obtained by consortium members contributing data if required. The final pooled, harmonised and cleaned dataset, as well as the deidentified, renamed CXR images, is stored on a secure cloud-based server. All analyses of existing CAD products, as well as the paediatric-optimised products, will be published in peer-reviewed publications and shared with other stakeholders like the WHO and donor and procurement organisations to guide policy updates and procurement pathways to ensure widespread uptake.
KW - Artificial Intelligence
KW - Chest imaging
KW - Diagnostic Imaging
KW - PAEDIATRICS
KW - Tuberculosis
UR - https://www.scopus.com/pages/publications/105027211444
UR - https://www.scopus.com/pages/publications/105027211444#tab=citedBy
U2 - 10.1136/bmjopen-2025-108668
DO - 10.1136/bmjopen-2025-108668
M3 - Article
C2 - 41526020
AN - SCOPUS:105027211444
SN - 2044-6055
VL - 16
JO - BMJ open
JF - BMJ open
IS - 1
M1 - e108668
ER -